首页> 外文期刊>The biochemical journal >The molecular-weight-dependence of the anti-coagulant activity of heparin
【24h】

The molecular-weight-dependence of the anti-coagulant activity of heparin

机译:肝素抗凝活性的分子量依赖性

获取原文
           

摘要

pIt is proposed that the anti-coagulant activity of heparin is related to the probability of finding, in a random distribution of different disaccharides, a dodecasaccharide with the sequence required for binding to antithrombin. It is shown that this probability is a function of the degree of polymerization of heparin. The hypothesis has been been tested with a series of narrow-molecular-weight-range fractions ranging from 5,600 to 36,000. The fractions having mol.wts. below 18,000 (comprising 85% of the original preparation) followed the predicted probability relationship as expressed by the proportion of molecules capable of binding to antithrombin. The probability that any randomly chosen dodecasaccharide sequence in heparin should bind to antithrombin was calculated to 0.022. The fraction with mol.wt. 36,000 contained proteoglycan link-region fragments, which may explain the deviation of the high-molecular-weight fractions from the hypothetical relationship. The relationship between anti-coagulant activity and molecular weight cannot be explained solely on the basis of availability of binding sites for antithrombin. The activity of high-affinity heparin (i.e. molecules containing high-affinity binding sites for antithrombin), determined either by a whole-blood clotting procedure or by thrombin inactivation in the presence of antithrombin, thus remained dependent on molecular weight. Possible explanations of this finding are discussed. One explanation could be a requirement for binding of thrombin to the heparin chain adjacent to antithrombin./p
机译:提出肝素的抗凝活性与在不同二糖的随机分布中发现具有结合抗凝血酶所需序列的十二糖的可能性有关。结果表明,该概率是肝素聚合度的函数。该假设已通过一系列从5,600到36,000的窄分子量范围的分数进行了测试。具有mol.wts的级分。低于18,000(占原始制剂的85%)的预测概率关系由能够与抗凝血酶结合的分子的比例表示。肝素中任何随机选择的十二糖序列应与抗凝血酶结合的概率经计算为0.022。具有mol.wt. 36,000包含蛋白聚糖连接区片段,这可能解释了高分子分数与假设关系的偏离。不能仅根据抗凝血酶结合位点的可用性来解释抗凝活性和分子量之间的关系。高亲和力肝素的活性(即含有抗凝血酶高亲和力结合位点的分子)是通过全血凝固程序或在存在抗凝血酶的情况下通过凝血酶失活来确定的,因此仍然取决于分子量。讨论了这一发现的可能解释。一种解释可能是要求凝血酶与抗凝血酶相邻的肝素链结合。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号